Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaDesign is a Japanese biotechnology company specializing in bioinformatics and computer-aided drug discovery (CADD). Founded in 1999, the company leverages structure-based drug design (SBDD) and protein modeling to assist pharmaceutical and chemical companies in identifying and optimizing lead compounds. Their core services include virtual screening of chemical libraries, protein structure prediction, and the analysis of genomic sequences to discover novel therapeutic targets. PharmaDesign operates as a strategic research partner, utilizing its proprietary computational platforms to reduce the time and cost associated with early-stage drug development. The company is recognized as a pioneer in the Japanese bioinformatics sector, providing deep expertise in protein-ligand interaction analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaDesign.